Zusammenfassung
Eine umweltbedingte Exposition mit den Platingruppenelementen (PGE) Platin, Palladium, Rhodium liegt im Bereich sehr niedriger, chronischer Dosen. Platin, Palladium und Rhodium werden aus KFZ-Abgaskatalysatoren in metallischer oder oxidischer Form in die Umwelt freigesetzt. Der Hauptpfad der Aufnahme dürfte flir den nicht am Arbeitsplatz besonders exponierten Menschen eine Ingestion von Staub, der Spuren dieser PGE enthält, sein. Daneben kann auch die Inhalation von Staubpartikeln eine gewisse Rolle spielen. Als mögliche Folgewirkungen einer chronischen Exposition im Niedrigdosisbereich sind für die PGE vornehmlich kanzerogene und sensibilisierende Wirkungen zu diskutieren.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Literatur
ACGIH (1990) Threshold limit values for chemical substances and physical agents and biological exposure indices for 1990–1991, Cincinnatti, Ohio, American Conference of Governmental Industrial Hygienists. p 31
ACGIH (1991) Rhodium and compounds. Documentation of the threshold limit values and biological exposure indices, 6th edn, pp 1337–1339
Beck DJ, Fisch JE (1980) Mutagenicity of platinum coordination complexes in Salmonella typhimurium. Mutat Res 77: 45–54
Bedello PG, Goitre M, Roncarolo G, Bundino S, Cane D (1987) Contact dermatitis to rhodium. Contact Dermatitis 17: 111–112
Bonatti S, Lohman PH, Berends F (1983) Induction of micronuclei in Chinese-hamster ovary cells treated with Pt co-ordination compounds. Mutat Res 116: 149–154
Biinger J, Storck J, Stalder K (1996) Cyto-and genotoxic effects of coordination complexes of platinum, palladium and rhodium in vitro. Int Arch Occup Environ Health 69: 33–38
Casper ES, Kelsen DP, Alcock NW, Young CW (1979) Platinum concentrations in bile and plasma following rapid and 6-hour infusions of cis-dichlorodiammineplatinum(II). Cancer Treat Rep 63: 2023–2025
D’Agostini RB, Lown BA, Morganti JB, Chapin E, Massaro EJ (1984) Effects on the development of offspring of female mice exposed to platinum sulfate or sodium hexachloroplatinate during pregnancy or lactation. J Toxicol Environ Health 13: 879–891
de la Cuadra J, Grau Massanes M (1991) Occupational contact dermatitis from rhodium and cobalt. Contact Dermatitis 25: 182–184
DFG (1980) Deutsche Forschungsgemeinschaft, MAK-Werte. Toxikologisch-arbeitsmedizinische Begriindungen. Platin und seine Verbindungen. VCH Verlagsgesellschaft, Weinheim
DFG (1981) Deutsche Forschungsgemeinschaft, MAK-Werte. Toxikologisch-arbeitsmedizinische Begründungen. Palladium und seine Verbindungen. VCH Verlagsgesellschaft, Weinheim
DFG (1997) Deutsche Forschungsgemeinschaft, MAK- und BAT-Wert-Liste. VCH Verlagsgesellschaft, Weinheim
Diwan BA, Anderson LM, Rehm S, Rice JM (1993) Transplacental carcinogenicity of cisplatin: initiation of skin tumors and induction of other preneoplastic and neoplastic lesions in SENCAR mice. Cancer Res 53: 3874–3876
Durbin P (1960) Metabolic characteristics within a chemical family. Health Phys 2: 225–238
Erck A, Sherwood E, Bear JL, Kimball AP (1976) The metabolism of rhodium(II) acetate in tumor-bearing mice. Cancer Res 36: 2404–2409
Gebel T, Lantzsch H, Pleflow K, Dunkelberg H (1997) Genotoxicity of platinum and palladium compounds in human and bacterial cells. Mutat Res 389: 183–190
Giraldi T, Sava G, Bertoli G, Mestroni G, Zassinovich G (1977) Antitumor action of two rhodium and ruthenium complexes in comparison with cis-diammine-dichloroplatinum(II). Cancer Res 37: 2662–2666
Hanigan MH, Gallagher BC, Taylor PT, Jr., Large MK (1994) Inhibition of gammaglutamyl transpeptidase activity by acivicin in vivo protects the kidney from cisplatininduced toxicity. Cancer Res 54: 5925–5929
Holbrook DJ, Washington ME, Leake HB (1976) Effects of platinum and palladium salts on parameters of drug metabolism in rat liver. J Toxicol Environ Health 1: 1067–1079
IARC (1987) Cisplatin. Overall evaluations of carcinogenicity: an updating of IARC Monographs Volumes 1 to 42. IARC Monographs on the Evaluation of Carcinogenic risks to humans, Suppl. 7. International Agency for Research on Cancer, Lyon
Kanematsu N, Hara M, Kada T (1980) Rec assay and mutagenicity studies on metal compounds. Mutat Res 77: 109–116
Lantzsch H, Gebel T (1997) Genotoxicity of selected metal compounds in the SOS chromotest. Mutat Res 389: 191–197
LaVelle JM, Krause RA (1986) Rhodium(III) complexes as genotoxic agents: photochemical effects and their implications. Mutat Res 172: 211–222
Lippard SJ (1987) Chemistry and molecular biology of platinum anticancer drugs. Pure Appl Chem 59: 731–742
Lippert B (1996) Struktur eines Cisplatin-DNA-Komplexes. Chemie in unserer Zeit 30: 49–50
Mailliet P, Segal Bendirdjian E, Kozelka J, Barreau M, Baudoin B, Bissery MC, Gontier S, Laoui A, Lavelle F, Le Pecq JB, Chottard JC (1995) Asymmetrically substituted ethylenediamine platinum(II) complexes as antitumor agents: synthesis and structure-activity relationships. Anticancer Drug Des 10: 51–73
Maquet JP, Theophanides T (1975) DNA-platinum interactions in vitro with trans-and cisPt(NH3)2C12. Bioinorg Chem 5: 59–66
Millard MM, Macquet JP, Theophanides T (1975) X-ray photoelectron spectroscopy of DNA-Pt complexes. Evidence of O6(Gua)-N7(Gua) chelation of DNA with cisdichlorodiamine platinum(II). Biochim Biophys Acta 402: 166–170
Moore W, Jr., Hysell D, Crocker W, Stara J (1975a) Biological fate of a single administration of 191Pt in rats following different routes of exposure. Environ Res 9: 152–158
Moore W, Jr., Hysell D, Hall L, Campbell K, Stara J (1975b) Preliminary studies on the toxicity and metabolism of palladium and platinum. Environ Health Perspect 10: 63–71
Moore W, Jr., Malanchuk M, Crocker W, Hysell D, Cohen A, Stara JF (1975c) Whole body retention in rats of different 191Pt compounds following inhalation exposure. Environ Health Perspect 12: 35–39
Moulon C, Vollmer J, Weltzien HU (1995) Characterization of processing requirements and metal cross-reactivities in T cell clones from patients with allergic contact dermatitis to nickel. Eur J Immunol 25: 3308–3315
Pinto AL, Lippard SJ (1985) Binding of the antitumor drug cis-diammine-dichloroplatinum(II) (cisplatin) to DNA. Biochem Biophys Acta 780: 167–180
Reibscheid EM, Zyngier S, Maria DA, Mistrone RJ, Sinisterra RD, Couto LG, Najjar R (1994) Antitumor effects of rhodium(II) complexes on mice bearing Ehrlich tumors. Braz J Med Biol Res 27: 91–94
Roshchin AV, Veselov VG, Panova AI (1984) Industrial toxicology of metals of the platinum group. J Hyg Epidemiol Microbiol Immunol 28: 17–24
TA Luft (1986) Erste allgemeine Verwaltungsvorschrift zum Bundes-ImmisionsschutzGesetz vom 27.02.1986. GMBI.: 95–144
Safirstein R, Daye M, Guttenplan JB (1983) Mutagenic activity and identification of excreted platinum in human and rat urine and rat plasma after administration of cisplatin. Cancer Lett 18: 329–338
Sava G, Giraldi T, Mestroni G, Zassinovich G (1983) Antitumor effects of rhodium(I), iridium(I), and ruthenium(II) complexes in comparison with cis-dichlorodiammino platinum(II) in mice bearing Lweis lung carcinoma. Chem Biol Interact 45: 1–6
Schroeder HA, Mitchener M (1971) Scandium, chromium(VI), gallium, yttrium, rhodium, palladium, indium in mice: effects on gromth and life span. J Nutr 101: 1431–1438
Takahara PM, Rosenzweig AC, Frederick CA, Lippard SJ (1995) Crystal structure of double-stranded DNA containing the major adduct of the anticancer drug cisplatin Nature 377: 649–652
Tothill P, Klys HS, Matheson LM, McKay K, Smyth JF (1992) The long-term retention of platinum in human tissues following the administration of cisplatin or carboplatin for cancer chemotherapy. Eur J Cancer 28a: 1358–1361
Uno Y, Morita M (1993) Mutagenic activity of some platinum and palladium complexes. Mutat Res 298: 269–275
US EPA (1985) Rhodium trichloride. In: US EPA Chemical Profiles, Washington DC
van der Veer JL, Peters AR, Reedijk J (1986) Reaction products from platinum(IV)amine compounds and 5’-GMP are mainly bis(5’-GMP)platinum(II)amine adducts. J Inorg Biochem 26: 137–142
Warren G, Abbott E, Schultz P, Bennett K, Rogers S (1981) Mutagenicity of a series of hexacoordinate rhodium(III) compounds. Mutat Res 88: 165–173
WHO (1991) Environmental Health Criteria - International programme on chemical safety. Platinum, vol 125, Geneva
Wiesmüller GA, Henne A, Leng G (1995) Metalle/Palladium. In: Wichmann HE, Schlipköter HW, Fülgraff G (Hrsg) Handbuch der Umweltmedizin, Kap VI-3, ecomed, Landsberg
Zinke T (1992) Palladium-Basis-Legierungen. Bundesgesundheitsblatt 11/92: 579–581
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Gebel, T. (1999). Toxikologisches Gefährdungspotential der Platingruppenelemente Platin, Palladium und Rhodium. In: Zereini, F., Alt, F. (eds) Emissionen von Platinmetallen. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-58611-8_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-58611-8_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-63665-3
Online ISBN: 978-3-642-58611-8
eBook Packages: Springer Book Archive